3716 — Cenra Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual cashflow statement for Cenra, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	658	659	589	391	386
Depreciation
Amortisation
Non-Cash Items	-149	-160	-172	-78.5	-25.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	124	-80.6	-541	-25	35.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	897	696	167	602	751
Capital Expenditures	-262	-208	-257	-247	-315
Purchase of Fixed Assets
Other Investing Cash Flow Items	116	87.5	-118	-85	188
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-146	-121	-375	-332	-127
Financing Cash Flow Items	-0.771	2.45	-3.28	-9.47	7.41
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-426	-769	-209	-247	-486
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	330	-185	-411	6.72	143